Mitophagy could fight Parkinson's disease through antioxidant action

被引:6
作者
Di Rita, Anthea [1 ,2 ]
Strappazzon, Flavie [1 ,2 ]
机构
[1] IRCCS Fdn Santa Lucia, I-00143 Rome, Italy
[2] Univ Roma Tor Vergata, Dept Biol, I-00133 Rome, Italy
关键词
mitochondrial selective degradation; neurodegeneration; oxidative stress; Parkinsonism; MITOCHONDRIAL-DNA DELETIONS; DOPAMINERGIC-NEURONS; OXIDATIVE STRESS; ALPHA-SYNUCLEIN; VITAMIN-E; MELATONIN PROTECTS; COENZYME Q(10); COMPLEX-I; LIFE-SPAN; BILE-ACID;
D O I
10.1515/revneuro-2018-0095
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
During aging, the process of mitophagy, a system that allows the removal of dysfunctional mitochondria through lysosomal degradation, starts to malfunction. Because of this defect, damaged mitochondria are not removed correctly, and their decomposing components accumulate inside the cells. Dysfunctional mitochondria that are not removed by mitophagy produce high amounts of reactive oxygen species (ROS) and, thus, cause oxidative stress. Oxidative stress, in turn, is very harmful for the cells, neuronal cells, in particular. Consequently, the process of mitophagy plays a crucial role in mitochondriarelated disease. Mitochondria' dysfunctions and oxidative stress are well-established factors contributing to Parkinson's disease (PD), one of the most common neurodegenerative disorders. In this review, we report various known antioxidants for PD treatments and describe the stimulation of mitophagy process as a novel and exciting method for reducing oxidative stress in PD patients. We describe the different mechanisms responsible for mitochondria removal through the mitophagy process. In addition, we review the functional connection between mitophagy induction and reduction of oxidative stress in several in vitro models of PD and also agents (drugs and natural compounds) already known to be antioxidants and to be able to activate mitophagy. Finally, we propose that there is an urgent need to test the use of mitophagy-inducing antioxidants in order to fight PD.
引用
收藏
页码:729 / 742
页数:14
相关论文
共 102 条
  • [1] ATTWELL D, 2011, J CEREB BLOOD FLOW M, V21, P1133
  • [2] Aurora RN, 2010, J CLIN SLEEP MED, V6, P85
  • [3] Coenzyme Q10 attenuates the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) induced loss of striatal dopamine and dopaminergic axons in aged
    Beal, MF
    Matthews, RT
    Tieleman, A
    Shults, CW
    [J]. BRAIN RESEARCH, 1998, 783 (01) : 109 - 114
  • [4] Neuroprotection by a novel brain permeable iron chelator, VK-28, against 6-hydroxydopamine lession in rats
    Ben Shachar, D
    Kahana, N
    Kampel, V
    Warshawsky, A
    Youdim, MBH
    [J]. NEUROPHARMACOLOGY, 2004, 46 (02) : 254 - 263
  • [5] Ben-Shachar D., 1992, ANN NEUROL, V1992, P32
  • [6] High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease
    Bender, A
    Krishnan, KJ
    Morris, CM
    Taylor, GA
    Reeve, AK
    Perry, RH
    Jaros, E
    Hersheson, JS
    Betts, J
    Klopstock, T
    Taylor, RW
    Turnbull, DM
    [J]. NATURE GENETICS, 2006, 38 (05) : 515 - 517
  • [7] AXOPLASMIC ORGANELLES AT NODES OF RANVIER .1. OCCURRENCE AND DISTRIBUTION IN LARGE MYELINATED SPINAL ROOT AXONS OF THE ADULT CAT
    BERTHOLD, CH
    FABRICIUS, C
    RYDMARK, M
    ANDERSEN, B
    [J]. JOURNAL OF NEUROCYTOLOGY, 1993, 22 (11): : 925 - 940
  • [8] FKBP8 recruits LC3A to mediate Parkin-independent mitophagy
    Bhujabal, Zambarlal
    Birgisdottir, Asa B.
    Sjottem, Eva
    Brenne, Hanne B.
    Overvatn, Aud
    Habisov, Sabrina
    Kirkin, Vladimir
    Lamark, Trond
    Johansen, Terje
    [J]. EMBO REPORTS, 2017, 18 (06) : 947 - 961
  • [9] Mitochondrial dysfunction activates lysosomal-dependent mitophagy selectively in cancer cells
    Biel, Thomas G.
    Rao, V. Ashutosh
    [J]. ONCOTARGET, 2018, 9 (01) : 995 - 1011
  • [10] Resveratrol, a red wine polyphenol, protects dopaminergic neurons in MPTP-treated mice
    Blanchet, Julie
    Longpre, Fanny
    Bureau, Genevieve
    Morissette, Marc
    DiPaolo, Therese
    Bronchti, Gilles
    Martinoli, Maria-Grazia
    [J]. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2008, 32 (05) : 1243 - 1250